Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer.
Watkins JM, Russo JK, Andresen N, Rountree CR, Zahra A, Mott SL, Herr DJ, O'Keefe J, Allen BG, Sharma AK, Buatti JM. Watkins JM, et al. Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):489-493. doi: 10.1016/j.rpor.2020.03.017. Epub 2020 Apr 27. Rep Pract Oncol Radiother. 2020. PMID: 32477014 Free PMC article.
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.
Seyedin SN, Mitchell DL, Mott SL, Russo JK, Tracy CR, Snow AN, Parkhurst JR, Smith MC, Buatti JM, Watkins JM. Seyedin SN, et al. Among authors: watkins jm. Pathol Oncol Res. 2019 Jan;25(1):209-215. doi: 10.1007/s12253-017-0349-5. Epub 2017 Oct 27. Pathol Oncol Res. 2019. PMID: 29079967 Free PMC article.
Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Furqan M, Snyders TP, Saqlain MU, Mott SL, Laux D, Snow A, Anderson CM, Watkins JM, Clamon GH. Furqan M, et al. Among authors: watkins jm. Cancer Med. 2019 Jun;8(6):2730-2739. doi: 10.1002/cam4.2139. Epub 2019 Apr 9. Cancer Med. 2019. PMID: 30968604 Free PMC article.
A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy.
Seyedin SN, Watkins JM, Mayo Z, Snow AN, Laszewski M, Russo JK, Mott SL, Tracy CR, Smith MC, Buatti JM, Caster JM. Seyedin SN, et al. Among authors: watkins jm. Adv Radiat Oncol. 2021 Aug 14;6(6):100778. doi: 10.1016/j.adro.2021.100778. eCollection 2021 Nov-Dec. Adv Radiat Oncol. 2021. PMID: 34934861 Free PMC article.
95 results